02315 BIOCYTOGEN-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.53X | Oper Margin | 16.8% |
|---|---|---|---|
| LT Debt/Equity | 41.3% | Net Margin | 3.4% |
| Total Debt/Equity | 68.4% | Return on Equity | 4.0% |
| Price/Book | 9.28X | Return on Assets | 1.4% |
| (HKD 20.600) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 35.67 | -422.09 | -674.90 | -667.29 | -257.84 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +108.5 | +37.5 | -1.1 | -158.8 | N/A |
| Earnings Per Share (HKD) | 0.09 | -1.06 | -1.771 | -1.841 | -1.998 |
| Earnings Per Share Growth (%) | +108.5 | +40.2 | +3.8 | +7.8 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 229.91 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.221 | 2.169 | 3.218 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 980.454 | 716.912 | +36.8 | 533.881 |
| Operating Result | 72.581 | -371.961 | -119.5 | -611.928 |
| Associates | -29.753 | -10.027 | +196.7 | -14.77 |
| Profit Before Taxation | 42.94 | -380.156 | -111.3 | -601.353 |
| Taxation | 9.403 | 2.796 | +236.3 | 0.804 |
| Profit /( Loss) After Taxation | 33.537 | -382.952 | -108.8 | -602.157 |
| Minority Interests | -0.005 | -0.001 | +400.0 | -0.212 |
| Net Profit | 33.542 | -382.951 | -108.8 | -601.945 |
| Earnings Per Share () | 0.0896 | -1.0597 | -108.5 | -1.7714 |
| Announcement Date | 2025-03-26 | 2024-03-27 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
